Novo Nordisk extends gains as Hims abandons $49 weight-loss pill

Zealand Pharma A/S

09/02/2026 08:13

** Shares in Novo Nordisk NOVOb.CO rise 8%, extending Friday's gains, after U.S. drug distributor Hims & Hers HIMS.N withdrew from the launch of the Danish pharma group's Wegovy drug at a lower price

** Novo Nordisk shares rose already 5.2% on Friday, breaking a three day losing streak, as the U.S. FDA said it would take actions against Hims & Hers

** Shares set for best day since December

** Peer Zealand Pharma ZELA.CO up 3%

(Reporting by Boleslaw Lasocki)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))